ADDvise Group AB (publ) has carried out a primary issuance of shares of series B of approximately SEK 100 million. The subscription price was determined through an accelerated book-building procedure.

ADDvise is an international life science group. Operating a decentralised ownership model, the group develops and acquires high quality companies within the business areas Lab and Healthcare. The group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market.

ABG Sundal Collier and Pareto Securities acted as Joint Bookrunners. Baker McKenzie acted as legal advisor to the banks with a capital markets team consisting of Joakim Falkner, Olof Larsson and Monica Ericson. 

Explore Our Newsroom